iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,725.00
-60.00 (-1.59%)
Apr 29, 2026, 11:40 AM KST

iNtRON Biotechnology Revenue

In the year 2025, iNtRON Biotechnology had annual revenue of 5.74B KRW, down -10.56%. iNtRON Biotechnology had revenue of 1.70B in the quarter ending December 31, 2025, with 12.02% growth.

Revenue
5.74B
Revenue Growth
-10.56%
P/S Ratio
20.85
Revenue / Employee
78.63M
Employees
73
Market Cap
119.66B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.74B-677.59M-10.56%
Dec 31, 20246.42B-3.17B-33.05%
Dec 31, 20239.59B-4.42B-31.57%
Dec 31, 202214.01B-15.30B-52.21%
Dec 31, 202129.31B-16.13B-35.49%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Macrogen195.27B
ORIENT BIO59.09B
Amicogen41.98B
CG Invites27.39B
GeneOne Life Science23.04B
Genexine5.81B
IMB Dx5.33B
ENCell5.26B
Revenue Rankings